AAAAAA

   
Results: 1-12 |
Results: 12
DOSE-INTENSITY OF A 4-DRUG CHEMOTHERAPY REGIMEN WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED PHASE-IIISTUDY
Authors: PUJOL JL DOUILLARD JY RIVIERE A QUOIX E LAGRANGE JL BERTHAUD P BARDONNETCOMTE M POLIN V GAUTIER V MILLERON B CHOMY F CHOMY P SPAETH D LECHEVALIER T
Citation: Jl. Pujol et al., DOSE-INTENSITY OF A 4-DRUG CHEMOTHERAPY REGIMEN WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED PHASE-IIISTUDY, Journal of clinical oncology, 15(5), 1997, pp. 2082-2089
IDARUBICIN AND HIGH-DOSE CYTARABINE - A NEW SALVAGE TREATMENT FOR REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA
Authors: DUFOUR P MORS R BERTHAUD P LAMY T BERGERAT JP HERBRECHT R MALOISEL F AUDHUY B LIOURE B GIRON C HURTELOUP P OBERLING F
Citation: P. Dufour et al., IDARUBICIN AND HIGH-DOSE CYTARABINE - A NEW SALVAGE TREATMENT FOR REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 22(3-4), 1996, pp. 329-334
A PROSPECTIVE RANDOMIZED TRIAL OF IDARUBICIN VS DAUNORUBICIN IN COMBINATION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA OF THE AGE GROUP-55TO GROUP-75
Authors: REIFFERS J HUGUET F STOPPA AM MOLINA L MARIT G ATTAL M GASTAUT JA MICHALLET M LEPEU G BROUSTET A PRIS J MARANINCHI D HOLLARD D FABERES C MERCIER M HURTELOUP P DANEL P TELLIER Z BERTHAUD P
Citation: J. Reiffers et al., A PROSPECTIVE RANDOMIZED TRIAL OF IDARUBICIN VS DAUNORUBICIN IN COMBINATION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA OF THE AGE GROUP-55TO GROUP-75, Leukemia, 10(3), 1996, pp. 389-395
RANDOMIZED STUDY OF NAVELBINE(R) AND CISP LATIN VERSUS VINDESINE AND CISPLATIN VERSUS NAVELBINE(R) ALONE IN 612 PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: LECHEVALIER T BRISGAND D PUJOL JL DOUILLARD JY MONNIER A RIVIERE A CHOMY P LEGROUMELLEC A RUFFIE P GOTTFRIED M GASPARD MH CHEVREAU C ALBEROLA V CIGOLARI S BESSON F MARTINEZ A BESENVAL M BERTHAUD P TURSZ T
Citation: T. Lechevalier et al., RANDOMIZED STUDY OF NAVELBINE(R) AND CISP LATIN VERSUS VINDESINE AND CISPLATIN VERSUS NAVELBINE(R) ALONE IN 612 PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), Bulletin du cancer, 83(5), 1996, pp. 385-394
TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE
Authors: PIGNON B WITZ F DESABLENS B LEPRISE PY FRANCOIS S LINASSIER C BERTHOU C CAILLOT D LIOURE B CAHN JY CASASSUS P SADOUN A AUDHUY B GUYOTAT D BRIERE J VILQUE JP BARANGER L POLIN V BERTHAUD P HURTELOUP P HERVE P HAROUSSEAU JL
Citation: B. Pignon et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE, British Journal of Haematology, 94(2), 1996, pp. 333-341
DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER (SCLC) - PRELIMINARY-RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: PUJOL JL DOUILLARD JY RIVIERE A POUDENX M QUOIX E SPAETH D CHOMY P LAFITTE JJ MONNIER A MILLERON B BERTHAUD P LECHEVALIER T
Citation: Jl. Pujol et al., DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER (SCLC) - PRELIMINARY-RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 78-78
RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS
Authors: LECHEVALIER T BRISGAND D DOUILLARD JY PUJOL JL ALBEROLA V MONNIER A RIVIERE A LIANES P CHOMY P CIGOLARI S GOTTFRIED M RUFFIE P PANIZO A GASPARD MH RAVAIOLI A BESENVAL M BESSEN F MARTINEZ A BERTHAUD P TURSZ T
Citation: T. Lechevalier et al., RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS, Journal of clinical oncology, 12(2), 1994, pp. 360-367
A 3-ARM TRIAL OF VINORELBINE (NAVELBINE) PLUS CISPLATIN, VINDESINE PLUS CISPLATIN, AND SINGLE-AGENT VINORELBINE IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - AN EXPANDED ANALYSIS
Authors: LECHEVALIER T PUJOL JL DOUILLARD JY ALBEROLA V MONNIER A RIVIERE A LIANES P CHOMY P CIGOLARI S BESSON F BERTHAUD P BRISGAND D BURRIS HA LIVINGSTON RB GRALLA R COLTMAN CA
Citation: T. Lechevalier et al., A 3-ARM TRIAL OF VINORELBINE (NAVELBINE) PLUS CISPLATIN, VINDESINE PLUS CISPLATIN, AND SINGLE-AGENT VINORELBINE IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - AN EXPANDED ANALYSIS, Seminars in oncology, 21(5), 1994, pp. 28-34
GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
Authors: WITZ F HAROUSSEAU JL CAHN JY ABGRALL JF BRIERE J SADOUN A GUYOTAT D HURTELOUP P MERCIER M BERTHAUD P
Citation: F. Witz et al., GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000231-10000231
PROSPECTIVE COMPARISON OF ALLOGENIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) AND UNPURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS POST REMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA (AML)
Authors: HAROUSSEAU JL PIGNON B WITZ F LINASSIER P LIOURE B LEPRISE PY CAHN JY DESABLENS B CAILLOT D IFRAH N ABGRALL JF SADOUN A GUYOTAT D MORS A CASASSUS P BRIERE J POLIN V BERTHAUD P HURTELOUP P
Citation: Jl. Harousseau et al., PROSPECTIVE COMPARISON OF ALLOGENIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) AND UNPURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS POST REMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000251-10000251
PHASE-I STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED MALIGNANCY
Authors: BERTHAUD P EUGENEJOLCHINE I SPIELMANN M LECHEVALIER T TURSZ T
Citation: P. Berthaud et al., PHASE-I STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED MALIGNANCY, Bulletin du cancer, 80(5), 1993, pp. 418-430
INDUCTION THERAPY FOLLOWED BY A UNIQUE INTENSIVE CONSOLIDATION COURSEIN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AGED 50 TO 65 - RESULTS OF THE GOELAM GROUP
Authors: PIGNON B HAROUSSEAU JL WITZ F DESABLENS B LEPRISE PY BOASSON M LINASSIER C ABGRALL JF SOLARY E LIOURE B CAHN JY CASASSUS P SADDOUN A AUDHUY B GUYOTAT D BRIERE J VILQUE JP DANEL P BERTHAUD P
Citation: B. Pignon et al., INDUCTION THERAPY FOLLOWED BY A UNIQUE INTENSIVE CONSOLIDATION COURSEIN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AGED 50 TO 65 - RESULTS OF THE GOELAM GROUP, Blood, 82(10), 1993, pp. 10000127-10000127
Risultati: 1-12 |